These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18289651)

  • 21. Posttreatment human papillomavirus testing for residual or recurrent high-grade cervical intraepithelial neoplasia: a pooled analysis.
    Onuki M; Matsumoto K; Sakurai M; Ochi H; Minaguchi T; Satoh T; Yoshikawa H
    J Gynecol Oncol; 2016 Jan; 27(1):e3. PubMed ID: 26463429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
    Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W
    BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
    Kjær SK; Frederiksen K; Munk C; Iftner T
    J Natl Cancer Inst; 2010 Oct; 102(19):1478-88. PubMed ID: 20841605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Practice Bulletin No. 140: management of abnormal cervical cancer screening test results and cervical cancer precursors.
    American College of Obstetricians and Gynecologists
    Obstet Gynecol; 2013 Dec; 122(6):1338-67. PubMed ID: 24264713
    [No Abstract]   [Full Text] [Related]  

  • 25. Risk of cervical intraepithelial neoplasia grade 2 or 3 after loop electrosurgical excision procedure associated with human papillomavirus type 16 variants.
    Xi LF; Kiviat NB; Wheeler CM; Kreimer A; Ho J; Koutsky LA
    J Infect Dis; 2007 May; 195(9):1340-4. PubMed ID: 17397005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pilot study of pNGVL4a-CRT/E7(detox) for the treatment of patients with HPV16+ cervical intraepithelial neoplasia 2/3 (CIN2/3).
    Alvarez RD; Huh WK; Bae S; Lamb LS; Conner MG; Boyer J; Wang C; Hung CF; Sauter E; Paradis M; Adams EA; Hester S; Jackson BE; Wu TC; Trimble CL
    Gynecol Oncol; 2016 Feb; 140(2):245-52. PubMed ID: 26616223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-treatment human papillomavirus status and recurrence rates in patients treated with loop electrosurgical excision procedure conization for cervical intraepithelial neoplasia.
    Du R; Meng W; Chen ZF; Zhang Y; Chen SY; Ding Y
    Eur J Gynaecol Oncol; 2013; 34(6):548-51. PubMed ID: 24601049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A growth model of human papillomavirus type 16 designed from cellular automata and agent-based models.
    Escobar Ospina ME; Perdomo JG
    Artif Intell Med; 2013 Jan; 57(1):31-47. PubMed ID: 23207013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of an HPV6/11/16/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infection.
    Haupt RM; Wheeler CM; Brown DR; Garland SM; Ferris DG; Paavonen JA; Lehtinen MO; Steben M; Joura EA; Giacoletti KE; Radley DR; James MK; Saah AJ; Sings HL;
    Int J Cancer; 2011 Dec; 129(11):2632-42. PubMed ID: 21491420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Artificial intelligence estimates the impact of human papillomavirus types in influencing the risk of cervical dysplasia recurrence: progress toward a more personalized approach.
    Bogani G; Ditto A; Martinelli F; Signorelli M; Chiappa V; Leone Roberti Maggiore U; Taverna F; Lombardo C; Borghi C; Scaffa C; Lorusso D; Raspagliesi F
    Eur J Cancer Prev; 2019 Mar; 28(2):81-86. PubMed ID: 29360648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lower genital tract intraepithelial neoplasia in HIV-infected women: guidelines for evaluation and management.
    Spitzer M
    Obstet Gynecol Surv; 1999 Feb; 54(2):131-7. PubMed ID: 9950005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Origin and immunoescape of uterine cervical cancer.
    Van Hede D; Langers I; Delvenne P; Jacobs N
    Presse Med; 2014 Dec; 43(12 Pt 2):e413-21. PubMed ID: 25448124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent high-risk human papillomavirus-induced anogenital dysplasia in chronic idiopathic CD4+ T lymphocytopaenia.
    Kreuter A; Wieland U; Hampl M
    Acta Derm Venereol; 2013 Nov; 93(6):759-60. PubMed ID: 23603889
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of human papillomavirus type 16/18 genotyping in predicting high-grade cervical/vaginal intraepithelial neoplasm in women with mildly abnormal Papanicolaou results.
    Guo M; Gong Y; Wang J; Dawlett M; Patel S; Liu P; Bevers TB; Sneige N
    Cancer Cytopathol; 2013 Feb; 121(2):79-85. PubMed ID: 23225501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of cervical precancer with human papillomavirus types other than 16 among HIV co-infected women.
    Massad LS; Xie X; Burk RD; D'Souza G; Darragh TM; Minkoff H; Colie C; Burian P; Palefsky J; Atrio J; Strickler HD
    Am J Obstet Gynecol; 2016 Mar; 214(3):354.e1-6. PubMed ID: 26433170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of hnRNP K and its interaction with HPV16 on cervical intraepithelial neoplasia].
    Ding L; Feng MJ; Liu CL; Wang L; Song ZC; Yang Q; Li XX; Song L; Gao W; Wang JT
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Dec; 39(12):1630-1635. PubMed ID: 30572391
    [No Abstract]   [Full Text] [Related]  

  • 37. Inverse correlation of cellular immune responses specific to synthetic peptides from the E6 and E7 oncoproteins of HPV-16 with recurrence of cervical intraepithelial neoplasia in a cross-sectional study.
    Sarkar AK; Tortolero-Luna G; Follen M; Sastry KJ
    Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S251-61. PubMed ID: 16188303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laboratory management of cervical intraepithelial neoplasia: proposing a new paradigm.
    Herfs M; Crum CP
    Adv Anat Pathol; 2013 Mar; 20(2):86-94. PubMed ID: 23399794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cold-knife conization versus photodynamic therapy with topical 5-aminolevulinic acid (5-ALA) in cervical intraepithelial neoplasia (CIN) II with associated human papillomavirus infection: a comparison of preliminary results.
    Bodner K; Bodner-Adler B; Wierrani F; Kubin A; Szölts-Szölts J; Spängler B; Grünberger W
    Anticancer Res; 2003; 23(2C):1785-8. PubMed ID: 12820459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.
    Rijkaart DC; Berkhof J; Rozendaal L; van Kemenade FJ; Bulkmans NW; Heideman DA; Kenter GG; Cuzick J; Snijders PJ; Meijer CJ
    Lancet Oncol; 2012 Jan; 13(1):78-88. PubMed ID: 22177579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.